The Toxoplasma gondii ME-49 strain upregulates levels of A20 that inhibit NF-κB activation and promotes apoptosis in human leukaemia T-cell lines

Parasites & Vectors
Qian ChenChen Lin

Abstract

Acute T-lymphocyte leukaemia is a form of haematological malignancy with abnormal activation of NF-κB pathway, which results in high expression of A20 and ABIN1, which constitute a negative feedback mechanism for the regulation of NF-κB activation. Clinical studies have found that acute T-lymphocyte leukaemia patients are susceptible to Toxoplasma gondii infection; however, the effect of T. gondii on the proliferation and apoptosis of human leukaemia T-cells remains unclear. Here, we used the T. gondii ME-49 strain to infect human leukaemia T-cell lines Jurkat and Molt-4, to explore the effect of T. gondii on proliferation and apoptosis, which is mediated by NF-κB in human leukaemia T-cells. The Tunel assay was used to detect cell apoptosis. Cell Counting Kit-8 was used to detect cell proliferation viability. The apoptosis level and the expression level of NF-κB related proteins in human leukaemia T-cells were detected by flow cytometry and Western blotting. Western blotting analyses revealed that the T. gondii ME-49 strain increased the expression of A20 and decreased both ABIN1 expression and NF-κB p65 phosphorylation. By constructing a lentiviral-mediated shRNA to knockdown the A20 gene in Jurkat T-cells and Molt-4 T-cells, ...Continue Reading

References

May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·T HaraK Takeshita
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J CaamañoC A Hunter
Dec 6, 2000·Arquivos de neuro-psiquiatria·E MacielA Melo
Feb 28, 2002·The Journal of Infectious Diseases·S ShapiraC A Hunter
Nov 6, 2004·The Biochemical Journal·Peter StorzAlex Toker
Jul 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Andy WullaertRudi Beyaert
May 11, 2006·The Journal of Biological Chemistry·Claudio MauroAntonio Leonardi
Oct 20, 2007·The EMBO Journal·Andrea OeckinghausDaniel Krappmann
Feb 12, 2008·Nature Immunology·Fabien RebeaudMargot Thome
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael DüwelDaniel Krappmann
Aug 22, 2009·Biochemical and Biophysical Research Communications·Shai CohenShirly Lahav-Baratz
May 25, 2011·The Journal of Experimental Medicine·Sambit K NandaPhilip Cohen
Sep 3, 2011·The Journal of Biological Chemistry·Linlin GaoEdward W Harhaj
Jun 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Supriya SrivastavPijush K Das
Feb 20, 2014·PLoS Neglected Tropical Diseases·Vasco RodriguesJérôme Estaquier
May 7, 2015·Seminars in Immunopathology·SuJin Hwang, Imtiaz A Khan
Nov 7, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Gungor Cagdas Dincel, Hasan Tarik Atmaca
May 8, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yi HuangJiahong Wu

❮ Previous
Next ❯

Citations

May 14, 2019·BioMed Research International·Nour MammariBertrand Courtioux

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
transfection

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis